• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, September 13, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Controlled Release Society names Steve Little Young Investigator of 2018

Bioengineer by Bioengineer
May 30, 2018
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Ric Evans/Swanson School of Engineering

PITTSBURGH (May 30, 2018) … The Controlled Release Society this week announced that University of Pittsburgh Professor Steven Little is the recipient of its 2018 Young Investigator award. The honor annually recognizes one individual in the world, 40 years of age or younger, for outstanding contributions in the science of controlled release. Dr. Little is the William Kepler Whiteford Endowed Professor and Chair of the Department of Chemical and Petroleum Engineering at Pitt's Swanson School of Engineering.

Dr. Little's focuses on novel drug delivery systems that mimic the body's own mechanisms of healing and resolving inflammation. This allows for dosages that are millions of times smaller than current medicine, and his next-generation treatments have shown promise for addressing a number of conditions including glaucoma, periodontal disease, wound healing, cancer, skin allergic dermatitis, and even transplantation of tissues and limbs. New "controlled release" systems developed by Dr. Little are applied once and then released over a period of days or months, depending on the medication.

His controlled release discoveries resulted in the co-founding of Pittsburgh-based Qrono Inc., which provides custom designed controlled release formulations for academic laboratories and agricultural and pharmaceutical companies.

Previous Young Investigator Award recipients include:

2017 Zhen Gu

2016 Ryan Donnelly

2015 Twan Lammers

2014 Suzie Pun

2013 Ali Khademhosseini

2012 Cory Berkland

2011 Molly Stevens

2010 Krish Roy

2009 Justin Hanes

2008 Samir Mitragotri

2007 David Putnam

2006 Stefaan De Smedt

2005 Mark Prausnitz

2004 Jean-Christophe Leroux

2003 Duncan Craig

2003 Glen Kwon

2002 Steve Schwendeman

2001 Jeffrey Cleland

2001 Saghir Akhtar

2000 Claus-Michael Lehr

1999 Derek O'Hagan

1998 Antonios Mikos

1997 Martyn Davies

1996 W. Mark Saltzman

1996 Joke Bouwstra

1995 Rainer Mueller

1994 Kam Leong

1993 Ruth Duncan

1992 Joachim Kohn

1992 Kinam Park

1991 Vincent Lee

1990 Patrick Couvreur

1989 Ronald Siegel

1988 Richard Guy

More About Dr. Little

Dr. Steven Little is a William Kepler Whiteford Endowed Professor of Chemical and Petroleum Engineering, Bioengineering, Pharmaceutical Sciences, Immunology, Ophthalmology and the McGowan Institute for Regenerative Medicine at the University of Pittsburgh. He received his PhD in Chemical Engineering from MIT in 2005, with his thesis winning the American Association for Advancement of Science's Excellence in Research Award.

Researchers in Dr. Little's Lab focus upon therapies that are biomimetic and replicate the biological function and interactions of living entities using synthetic systems. Areas of study include bioengineering, chemistry, chemical engineering, ophthalmology, and immunology, and the health issues addressed include autoimmune disease, battlefield wounds, cancer, HIV, ocular diseases, and transplantation. Dr. Little currently has 10 provisional, 2 pending, and 5 issued patents.

Dr. Little has been recognized by national and international awards including the Curtis W. McGraw Research Award from the ASEE, being elected as a fellow of the BMES and AIMBE, a Carnegie Science Award for Research, the Society for Biomaterials' Young Investigator Award, the University of Pittsburgh's Chancellor's Distinguished Research Award, being named a Camille Dreyfus Teacher Scholar, being named an Arnold and Mabel Beckman Young Investigator, and being elected to the Board of Directors of the Society for Biomaterials.

In addition, Dr. Little's exceptional teaching and leadership in education have also been recognized by both the University of Pittsburgh's Chancellor's Distinguished Teaching Award and a 2nd Carnegie Science Award for Post-Secondary Education. Dr. Little was also recently named one of Pittsburgh Magazine's 40 under 40, a "Fast Tracker" by the Pittsburgh Business Times, and also one of only five individuals in Pittsburgh who are "reshaping our world" by Pop City Media.

###

About the Department of Chemical and Petroleum Engineering

The Swanson School's Department of Chemical and Petroleum Engineering serves undergraduate and graduate engineering students, the University and industry, through education, research, and participation in professional organizations and regional/national initiatives. Active areas of research in the Department include Biological and Biomedical Systems; Energy and Sustainability; and Materials Modeling and Design. The faculty holds a record of success in obtaining research funding such that the Department ranks within the top 25 U.S. Chemical Engineering departments for Federal R&D spending in recent years with annual research expenditures exceeding $7 million.

Media Contact

Paul Kovach
[email protected]
412-624-0265

http://www.pitt.edu

Original Source

http://www.engineering.pitt.edu/News/2018/Steve-Little-CRS-YIA/

Share12Tweet8Share2ShareShareShare2

Related Posts

Adverse Events in Asian Adults on Brivaracetam

September 13, 2025

ARFID hos förskolebarn: En screeningsstudie

September 13, 2025

Insights on Menstrual Health in Eating Disorder Units

September 12, 2025

Nicotine Dependence Linked to Health Behaviors in Korean Smokers

September 12, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    153 shares
    Share 61 Tweet 38
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • Physicists Develop Visible Time Crystal for the First Time

    65 shares
    Share 26 Tweet 16
  • A Laser-Free Alternative to LASIK: Exploring New Vision Correction Methods

    49 shares
    Share 20 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Advancing Liver Transplantation for Cancer with Genomics

Exploring Water Absorption in Footballs: Leather vs. Synthetic

Grape and Olive Waste Transformed Into Asphalt Antioxidants

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.